Mostrar el registro sencillo del ítem
Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases
dc.contributor.author | Rodríguez Padial, Luis | |
dc.contributor.author | Barón Esquivias, Gonzalo | |
dc.contributor.author | Hernández-Madrid, Antonio | |
dc.contributor.author | Marzal Martín, Domingo | |
dc.contributor.author | Pallarés-Carratalá, Vicente | |
dc.date.accessioned | 2017-06-28T16:04:04Z | |
dc.date.available | 2017-06-28T16:04:04Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Padial, L. R., Baron-Esquivias, G., Madrid, A. H., Martín, D. M., Pallares-Carratala, V., & Sierra, A. (2016). Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases. Cardiology and therapy, 5(1), 75-82 | ca_CA |
dc.identifier.issn | 2193-8261 | |
dc.identifier.issn | 2193-6544 | |
dc.identifier.uri | http://hdl.handle.net/10234/168131 | |
dc.description.abstract | Cardiovascular diseases are the leading cause of death in the world. Coronary artery diseases, atrial fibrillation or hypertensive heart disease, are among the most important cardiovascular disorders. Hypertension represents a significant risk factor for cardiovascular mortality; thus, control of high blood pressure has become a priority to prevent major complications. Although the choice of drugs for treating hypertension remains controversial, extensive clinical evidences point to calcium channel blockers as first-line agents. Diltiazem, a non-dihydropyridine calcium channel blocker, is an effective and safe antihypertensive drug, alone or in combination with other agents. Diltiazem lowers myocardial oxygen demand through a reduction in heart rate, blood pressure, and cardiac contractility, representing also a good alternative for the treatment of stable chronic angina. Furthermore, diltiazem reduces conduction in atrioventricular node, which is also useful for heart rate control in patients with atrial fibrillation. In this review, clinical experts highlight studies on diltiazem effectiveness and safety for the treatment of several cardiovascular diseases and make evidence-based recommendations regarding the management of diltiazem in the clinical prac | ca_CA |
dc.description.sponsorShip | Sponsorship for this review and the article processing charges was funded by Lacer Spain. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published. Writing assistance in the preparation of this manuscript was provided by Patricia Rodriguez, PhD, and editorial assistance was provided by Springer Healthcare. Support for this assistance was funded by Lacer Spain. | ca_CA |
dc.format.extent | 8 p. | ca_CA |
dc.format.mimetype | application/pdf | ca_CA |
dc.language.iso | eng | ca_CA |
dc.publisher | Springer Verlag (Germany) | ca_CA |
dc.relation.isPartOf | Cardiology and therapy, 2016, vol. 5, núm. 1 | ca_CA |
dc.relation.isPartOf | An erratum to this article can be found at http://dx.doi.org/10.1007/s40119-016-0062-6. | |
dc.rights | © The Author(s) 2016. This article is published with open access at Springerlink.com This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. | ca_CA |
dc.rights | Atribución-NoComercial 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.subject | Angina | ca_CA |
dc.subject | Atrial arrhythmia | ca_CA |
dc.subject | Calcium channel blocker (CCB) | ca_CA |
dc.subject | Diltiazem | ca_CA |
dc.subject | Hypertension | ca_CA |
dc.title | Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases | ca_CA |
dc.type | info:eu-repo/semantics/article | ca_CA |
dc.identifier.doi | http://dx.doi.org/ 10.1007/s40119-016-0059-1 | |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca_CA |
dc.relation.publisherVersion | https://link.springer.com/article/10.1007/s40119-016-0059-1 | ca_CA |
dc.type.version | info:eu-repo/semantics/publishedVersion |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
MED_Articles [673]
Articles de publicacions periòdiques
Excepto si se señala otra cosa, la licencia del ítem se describe como: © The Author(s) 2016. This article is published with open access at Springerlink.com
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.